Daniel Griffing’s Post

View profile for Daniel Griffing, graphic

Managing Partner at GS & Partners LLC

Artificial Intelligence (AI) was a major theme at this year's JP Morgan Healthcare Conference. Check out our most recent blog which outlines several key areas where AI could help to accelerate the development of gene therapy in the years ahead. #genetherapy #newproductdevelopment #biotechnology

Gene therapy (GTx) holds immense promise in treating genetic disorders. Still, the development process and the ability of GTx companies to secure funding and advance their development programs have historically been hindered by various challenges. Read our latest blog post on how AI could help to address these challenges and create a competitive advantage. #genetherapy #biotech #newproductplanning https://lnkd.in/eHAkvbaN

Revolutionizing Gene Therapy: Biotech and the AI Advantage

Revolutionizing Gene Therapy: Biotech and the AI Advantage

griffingspeizer.com

To view or add a comment, sign in

Explore topics